Key result
This review summarizes recently completed and ongoing clinical trials examining the effects of endothelin receptor antagonists in patients with heart failure, coronary artery disease, and hypertension.
Why the study?
What are the effects of endothelin receptor antagonists in patients with heart failure, CAD, arterial hypertension, and pulmonary hypertension?
What are the effects of endothelin receptor antagonists in patients with heart failure, CAD, arterial hypertension, and pulmonary hypertension?
This review summarizes the clinical trials examining the effects of endothelin receptor antagonists across various cardiovascular conditions including heart failure, coronary artery disease, and pulmonary hypertension.
No takes yet. Share an insight, caveat, or question.
Endothelin antagonists remain investigational across HF, CAD, and hypertension; this synthesis leaves open their therapeutic positioning pending definitive trials.
Neunteufl et al. (2002) conducted a review in Heart failure, coronary artery disease, arterial hypertension, and pulmonary hypertension. Endothelin receptor antagonists was evaluated. This review summarizes recently completed and ongoing clinical trials examining the effects of endothelin receptor antagonists in patients with heart failure, coronary artery disease, and hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: